Pneumococcal Vaccines Market Predicted to Surpass US $18,456.5 Mn by 2028: Pfizer Inc., Sanofi S.A., GlaxoSmithKline Plc., and Merck & Co.
Future Market Insights (FMI) delivers the key insights on the global pneumococcal vaccines market in its upcoming report titled "Pneumococcal Vaccines Market: Global Industry Analysis 2013–2017 and Opportunity Assessment 2018 – 2028". In terms of revenue, the global pneumococcal vaccines market is projected to register a CAGR of 9.1% over the forecast period.
View full press release